LIGAND PHARMACEUTICALS INCORPORATED Discontinued Operation, Tax Effect of Discontinued Operation
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Discontinued Operation, Tax Effect of Discontinued Operation of $400.00 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation · last filed 2016-11-14
- LIGAND PHARMACEUTICALS INCORPORATED discontinued operation, tax effect of discontinued operation for the quarter ending 2016-09-30 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED discontinued operation, tax effect of discontinued operation for the quarter ending 2016-06-30 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED discontinued operation, tax effect of discontinued operation for the quarter ending 2016-03-31 was $400.00K.
- LIGAND PHARMACEUTICALS INCORPORATED discontinued operation, tax effect of discontinued operation for the quarter ending 2012-12-31 was $1.52M.
- LIGAND PHARMACEUTICALS INCORPORATED discontinued operation, tax effect of discontinued operation for fiscal 2013 was $1.51M, a 0.00% change from fiscal 2012.
- LIGAND PHARMACEUTICALS INCORPORATED discontinued operation, tax effect of discontinued operation for fiscal 2012 was $1.51M.
| Period end | Discontinued Operation, Tax Effect of Discontinued Operation 3 month | Discontinued Operation, Tax Effect of Discontinued Operation 3 month as first filed | Discontinued Operation, Tax Effect of Discontinued Operation 6 month | Discontinued Operation, Tax Effect of Discontinued Operation 6 month as first filed | Discontinued Operation, Tax Effect of Discontinued Operation 9 month | Discontinued Operation, Tax Effect of Discontinued Operation 9 month as first filed | Discontinued Operation, Tax Effect of Discontinued Operation 12 month | Discontinued Operation, Tax Effect of Discontinued Operation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $400.00K 10-Q · filed 2016-11-14 | |||||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-14 | $400.00K 10-Q · filed 2016-11-14 | ||||||
| 2016-03-31 | $400.00K 10-Q · filed 2016-11-14 | |||||||
| 2013-12-31 | $1.51M 10-K · filed 2014-12-01 | |||||||
| 2012-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $1.52M derived: sum of 2 quarters · filed 2015-02-23 | $1.33M derived: sum of 3 quarters · filed 2015-02-23 | $1.51M 10-K · filed 2015-02-23 | -$1.51M 10-K · filed 2013-03-14 | |||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$191.00K derived: sum of 2 quarters · filed 2013-11-08 | -$14.00K 10-Q · filed 2013-11-08 | $14.00K 10-Q · filed 2012-11-14 | ||||
| 2012-06-30 | -$191.00K 10-Q · filed 2013-08-01 | $191.00K 10-Q · filed 2012-08-08 | -$14.00K 10-Q · filed 2013-08-01 | $14.00K 10-Q · filed 2012-08-08 | ||||
| 2012-03-31 | $177.00K 10-Q · filed 2013-05-08 |